Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Volkmann

Showing results (131-140 of 198) with videos related to

Pageof 20
Sort By:
Calcified Tissue International|March 14, 1998
Different behavior of human osteoblast-like cells isolated from normal and heterotopic bone In vitroS Sell, C Gaissmaier, J Fritz, et al.
ACR Open Rheumatology|August 18, 2023
Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory TherapyElizabeth R Volkmann, Holly Wilhalme, Shervin Assassi, et al.
Journal of Periodontology|December 7, 2007
CCL28 effects on periodontal pathogensHeather R Watkins, Carol A Lapp, Philip J Hanes, et al.
Frontiers in Immunology|October 27, 2025
Ultra-processed food intake is associated with increased gastrointestinal tract symptoms and alterations in gut microbiota in patients with systemic sclerosisJu Young Lee, Swapna Mahurkar-Joshi, Arissa Young, et al.
Annals of the Rheumatic Diseases|February 22, 2022
Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung diseaseShervin Assassi, Elizabeth R Volkmann, W Jim Zheng, et al.
Arthritis Care & Research|December 28, 2022
Associations Between Patterns of Esophageal Dysmotility and Extra-Intestinal Features in Patients With Systemic SclerosisAna E Tucker, Jamie Perin, Elizabeth R Volkmann, et al.
Arthritis Care & Research|October 16, 2020
Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic SclerosisZsuzsanna H McMahan, Ana E Tucker, Jamie Perin, et al.
ACR Open Rheumatology|April 23, 2024
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal MicrobiotaKristofer Andréasson, Tor Olofsson, Venu Lagishetty, et al.
Arthritis Care & Research|December 23, 2024
Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung DiseaseElizabeth R Volkmann, Holly Wilhalme, Donald P Tashkin, et al.
ACR Open Rheumatology|May 21, 2020
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study IIElizabeth R Volkmann, Donald P Tashkin, Holly LeClair, et al.
Pageof 20

Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
Calcified Tissue International|March 14, 1998
Different behavior of human osteoblast-like cells isolated from normal and heterotopic bone In vitroS Sell, C Gaissmaier, J Fritz, et al.
ACR Open Rheumatology|August 18, 2023
Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory TherapyElizabeth R Volkmann, Holly Wilhalme, Shervin Assassi, et al.
Journal of Periodontology|December 7, 2007
CCL28 effects on periodontal pathogensHeather R Watkins, Carol A Lapp, Philip J Hanes, et al.
Frontiers in Immunology|October 27, 2025
Ultra-processed food intake is associated with increased gastrointestinal tract symptoms and alterations in gut microbiota in patients with systemic sclerosisJu Young Lee, Swapna Mahurkar-Joshi, Arissa Young, et al.
Annals of the Rheumatic Diseases|February 22, 2022
Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung diseaseShervin Assassi, Elizabeth R Volkmann, W Jim Zheng, et al.
Arthritis Care & Research|December 28, 2022
Associations Between Patterns of Esophageal Dysmotility and Extra-Intestinal Features in Patients With Systemic SclerosisAna E Tucker, Jamie Perin, Elizabeth R Volkmann, et al.
Arthritis Care & Research|October 16, 2020
Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic SclerosisZsuzsanna H McMahan, Ana E Tucker, Jamie Perin, et al.
ACR Open Rheumatology|April 23, 2024
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal MicrobiotaKristofer Andréasson, Tor Olofsson, Venu Lagishetty, et al.
Arthritis Care & Research|December 23, 2024
Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung DiseaseElizabeth R Volkmann, Holly Wilhalme, Donald P Tashkin, et al.
ACR Open Rheumatology|May 21, 2020
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study IIElizabeth R Volkmann, Donald P Tashkin, Holly LeClair, et al.
Pageof 20